Committee of the Whole L5. Promoting comprehensive and scientific evidence-based early prevention

Slovenia: we had constructive informals that redefined the word ‘flexibility’ but we thank all delegates for their constructive approach. We confirmed to delete PP11bis, amend PP11ter and this is agreed in informals. Chair: What is the feeling of the room regarding PP11bis and PP11ter? Are there any comments? I see none. Let’s consider both agreed …

Read more

Committee of the Whole – L7. Intensifying efforts to address the proliferation of uncontrolled and designer precursors used in the illicit manufacture of drugs

L7. Intensifying efforts to address the proliferation of uncontrolled and designer precursors used in the illicit manufacture of drugs  USA: We believe its acceptable. I think Iran would like to maintain OP6bis? We include language on human rights, national sovereignty … as my Canadian colleague pointed out. The suggestion of the distinguished delegation from China …

Read more

Side event: Eliminating Structural Racism against Africans and people of African Descent in drug policy legal frameworks and practice

Organised by the Centro de Estudios Legales y Sociales (CELS) Asociación Civil with the support of the International Service for Human Rights Luciana Pol, Senior Fellow Security Policy & Human Rights CELS: Customary comment in these events is to say that this is a timely debate. However, in this case, we cannot say that because …

Read more

Side Event:Disparities in access to internationally controlled essential medicines in the Caribbean

IAHPC Welcome and Housekeeping Moderator: Dr. Katherine Pettus, Information and Partnerships Director, IAHPC Opening by HE Ambassador Cheryl Spencer, Permanent Representative of Jamaica to the United Nations, Vienna Dr. Dingle Spence Consultant in Oncology and Palliative Medicine President of the Caribbean Palliative Care Association (CARIPALCA) Verna Edwards (DPharm) Dept. of Standards and Regulations, Ministry of …

Read more